RNAC
Cartesian Therapeutics Inc.
8.00$
+2.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Cartesian Therapeutics Inc. (RNAC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -74 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13 | -22 | -20 | -52 | -59 | -51 | 35 | -60 | -32 | -51 | -24 | -74 | |
| 0.9 | 1.0 | 0.8 | 0.8 | 1.0 | 2.0 | 0.7 | 1.3 | 1.3 | 0.8 | 1.2 | 3.0 | |
| 1.2 | 1.1 | 2.1 | 4.1 | 5.7 | 5.2 | 5.4 | 7.7 | 11 | 23 | 6.6 | 11 | |
| 1.4 | 1.2 | 2.5 | 5.4 | 6.0 | 6.4 | 17 | 11 | -8.9 | – | – | – | |
| -2.1 | 0.4 | 13 | 7.1 | -0.8 | -4.5 | 85 | -48 | -60 | 5.0 | -5.8 | -8.1 | |
| 0.2 | 1.2 | 0.6 | 0.7 | 0.9 | 0.0 | 0.8 | 1.1 | 1.2 | 0.2 | 9.1 | 5.5 | |
| -0.2 | -4.7 | -22 | -2.1 | 25 | 0.2 | -0.7 | -17 | -15 | 35 | -8.7 | -5.5 | |
| – | – | 4.6 | 25 | – | 0.0 | 0.2 | – | – | – | – | – | |
| 0.1 | 33 | 72 | 0.2 | 0.2 | 0.0 | 0.2 | 0.2 | 0.2 | -6.2 | 0.0 | – | |
| 4.5 | 11 | 8.0 | 8.0 | -2.8 | -2.8 | 1.0 | 0.0 | 0.0 | -27 | 0.0 | – | |
| 25 | 44 | 68 | 66 | 0.7 | 105 | 14 | 53 | 39 | -13 | 168 | -8.1 | |
| 8.5 | 17 | 26 | 12 | -33 | 53 | 49 | -25 | -7.4 | -30 | 136 | -87 | |
| -13 | -24 | -20 | -53 | -60 | -51 | 34 | -61 | -33 | -51 | -33 | -79 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.